The Greedy Potamus discusses key highlights from the past week in stocks. Learn about key economic reports and individual stocks that defined the week.

The Greedy Potamus discusses key highlights from the past week in stocks. Learn about key economic reports and individual stocks that defined the week.

Here's an update on our recent stock picks. RTX rallied to a 2025 high on July 30, 2025, following strong Q2 earnings, raised revenue guidance, and Raytheon's MTS-A HD targeting system launch on July 28. RBC Capital upgraded RTX's price target to $170. For picks from July 20, 2025, ASTS saw a -6.23% 5-day return and LLY a 5.31% return. TEM, recommended on July 23, 2025, registered a -4.5% 5-day return, though it was up 6% mid-period.

Today's episode of "GP Stocks Reasonings" focused entirely on Tempus AI (TEM), presenting it as a high-risk, high-reward opportunity. Technical analysis reveals bullish momentum, with the stock's current price above its 5-day and 10-day moving averages and a positive MACD, suggesting potential for a breakout. Fundamentally, TEM exhibits strong growth driven by its Genomics and Data Services segments, with a notable 75.4% Year-over-Year revenue increase in Q1 2025 and a strategic partnership with AstraZeneca/Pathos. However, investors should be aware of the company's high debt-to-equity ratio (2.45), negative net income, and ongoing legal risks, which temper optimism despite its strong growth drivers.

--------------------------------------------------------------------------------
Financial Disclaimer: This analysis, derived from historical data and provided information, is for general insights only and is not tailored financial advice. It does not constitute a recommendation to purchase or sell any stock and does not account for individual investment objectives or financial circumstances. Investors should be aware that our analysis might not include the most recent, price-sensitive company announcements or qualitative information.